Caroline L. Smith

发表

Semiochemical Investigations of the Insidious Flower Bug, Orius insidiosus (Say)

J. R. Aldrich, J. E. Oliver, G. Dively, 2007, Journal of Chemical Ecology.

Plasmacytoid dendritic cells prime IFN‐γ‐secreting melanoma‐specific CD8 lymphocytes and are found in primary melanoma lesions

V. Cerundolo, M. Colonna, M. Cella, 2003, European journal of immunology.

Emerging roles of melanocortin receptor accessory proteins (MRAP and MRAP2) in physiology and pathophysiology.

Caroline L. Smith, N. Berruien, Caroline L. Smith, 2020, Gene.

C-reactive protein and asymmetric dimethylarginine: markers or mediators in cardiovascular disorders?

Caroline L. Smith, Caroline L. Smith, Caroline L. Smith, 2007, Current pharmaceutical design.

Cardiovascular tests: use & limits of biochemical markers - therapeutic measurements of ADMA involved in cardiovascular disorders.

P. Vallance, Caroline L. Smith, Caroline L. Smith, 2005, Current pharmaceutical design.

Active Tumor-Specific Immune Response CTL Identifies Melanoma Patients with an A Shift in the Phenotype of Melan-A-Specific

A. Harris, F. Sallusto, V. Cerundolo, 2000 .

Effects of ADMA upon gene expression : an insight into the pathophysiological significance of raised plasma ADMA

M. Hubank, P. Vallance, J. Leiper, 2005 .

Immunodominance of Poxviral-Specific CTL in a Human Trial of Recombinant-Modified Vaccinia Ankara1

A. Harris, V. Pasquetto, D. Tscharke, 2005, The Journal of Immunology.

Vaccinia Ankara in a Human Trial of Recombinant-Modified Immunodominance of Poxviral-Specific CTL

A. Harris, V. Pasquetto, A. Sette, 2005 .

Running Title: A MOLECULAR EXPLANATION FOR HIGH GLUCOSE-ELICITED ENDOTHELIAL DYSFUNCTION

M. Crabtree, M. Goligorsky, G. Lam, 2008 .

A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response1

A. Harris, F. Sallusto, A. Lanzavecchia, 2000, The Journal of Immunology.

Immunotherapy of colorectal cancer.

V. Cerundolo, N. Dulphy, M. Salio, 2002, British medical bulletin.

Disruption of methylarginine metabolism impairs vascular homeostasis

P. Vallance, J. Murray-Rust, N. McDonald, 2007, Nature Medicine.

Selective substrate-based inhibitors of mammalian dimethylarginine dimethylaminohydrolase.

P. Vallance, J. Leiper, D. Selwood, 2005, Journal of medicinal chemistry.

The in vitro metabolism and in vivo pharmacokinetics of the bacterial β-glucuronidase inhibitor UNC10201652

M. Redinbo, I. Wilson, P. Butler, 2022, Xenobiotica; the fate of foreign compounds in biological systems.

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence

A. Harris, V. Cerundolo, P. Coulie, 2005, International journal of cancer.

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA

M. Hubank, P. Vallance, J. Leiper, 2005, PLoS medicine.

Heterologous Prime-Boost Vaccination in Tumor Immunotherapy

M. Palmowski, Caroline L. Smith, C. Smith, 2004 .

Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS.

M. Crabtree, M. Goligorsky, G. Lam, 2008, American journal of physiology. Heart and circulatory physiology.

Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype.

P. Vallance, J. Leiper, Caroline L. Smith, 2003, Biochemical and biophysical research communications.

The significance of regulation and land use patterns on natural gas resource estimates in the Marcellus shale

Caroline L. Smith, Andrew Blohm, Jeremy Peichel, 2012 .